Global Factor VIII Deficiency Treatment Market: Restraint
High cost associated with hemophilia treatment
The major factors that can hamper the growth of the Global factor VIII deficiency treatment market over the forecast period include the high cost of hemophilia treatment. For instance, according to National Hemophilia Foundation, in May 2021, the average 6-month cost of hemophilia treatment is around US$ 300,000.
Global factor VIII deficiency treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients